These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21381275)

  • 1. [Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis?].
    Bochet M; Garin N; Janssens JP; Gerstel E
    Rev Med Suisse; 2011 Feb; 7(280):308, 310-2. PubMed ID: 21381275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides for Clinically Significant Bronchiectasis in Adults: Who Should Receive This Treatment?
    Hill AT
    Chest; 2016 Dec; 150(6):1187-1193. PubMed ID: 27591924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology and treatment of bronchectasis].
    Turcanu AM; Mihăescu T
    Pneumologia; 2011; 60(1):26-9. PubMed ID: 21548197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical challenges in managing bronchiectasis.
    Tsang KW; Bilton D
    Respirology; 2009 Jul; 14(5):637-50. PubMed ID: 19659645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC
    Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.
    Masekela R; Green RJ
    Mediators Inflamm; 2012; 2012():134605. PubMed ID: 22570510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Wu Q; Shen W; Cheng H; Zhou X
    Respirology; 2014 Apr; 19(3):321-9. PubMed ID: 24417869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.
    Fan LC; Lu HW; Wei P; Ji XB; Liang S; Xu JF
    BMC Infect Dis; 2015 Mar; 15():160. PubMed ID: 25888483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review.
    Shi ZL; Peng H; Hu XW; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):171-8. PubMed ID: 24076368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment options for bronchiectasis.
    Metersky ML
    Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antiinflammatory therapy and macrolides in bronchiectasis.
    Feldman C
    Clin Chest Med; 2012 Jun; 33(2):371-80. PubMed ID: 22640852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D; Soy-Muner D; Soler-Porcar N
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide treatment in patients with bronchiectasis: more attention should be paid to the number of exacerbations.
    Gao YH; Guan WJ; Xu G; Chen RC
    Pulm Pharmacol Ther; 2014 Apr; 27(2):213-4. PubMed ID: 24397907
    [No Abstract]   [Full Text] [Related]  

  • 14. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
    Kapur N; Masters IB; Chang AB
    Respir Med; 2009 Nov; 103(11):1681-7. PubMed ID: 19501498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term macrolide treatment in adult chronic bronchial diseases: benefits and limits].
    Jouneau S; Desrues B
    Presse Med; 2014 May; 43(5):510-9. PubMed ID: 24631048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to "Letter to the Editor" by Serisier regarding "effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review".
    Shi ZL; Peng H; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):180-1. PubMed ID: 24731870
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA
    Rev Alerg Mex; 2006; 53(3):108-22. PubMed ID: 16970113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antibiotic treatment of bronchiectasis with azithromycin.
    Davies G; Wilson R
    Thorax; 2004 Jun; 59(6):540-1. PubMed ID: 15170047
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibiotic treatment for prevention of infectious complications in joint replacement].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Apr; 73(2):108-14. PubMed ID: 16735008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.